News from the healthcare data industry
Series B Round to Accelerate PurpleLab’s Investment in Real-World Evidence Solutions Built on the Company’s HealthNexus™ Platform September 12, 2022 09:05 AM Eastern Daylight Time WAYNE, Pa.–(BUSINESS WIRE)–PurpleLab, Inc. today announced a $40 million Series B funding round led by Primus Capital, which joins existing investor Edison Partners. TripleTree served as the exclusive…
Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines. Source: https://www.outsourcing-pharma.com/Article/2022/09/12/real-world-evidence-helps-accelerate-research-wolters-kluwer-health?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Despite substantial progress made in cancer research to date, there is much about the disease that remains a mystery. The facts are in the figures. In 2020 alone, 1.3 million people in the EU lost their lives to cancer – a figure that is expected to increase by more than…
To facilitate FDA’s internal tracking of submissions to the Agency that include real-world data (RWD) and real-world evidence (RWE), this guidance encourages sponsors and applicants to identify in their submission cover letters certain uses of RWD/RWE. This guidance does not address FDA’s substantive review of the RWD/RWE submitted as part…
Lyon, France, September 9, 2022 – Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies across the world….
September 09, 2022 10:50 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Verily today announced a $1 billion dollar investment round led by Alphabet, that will be used to support the expansion of Verily’s businesses focused on precision health. Verily is also announcing new roles for the company’s top leadership….
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced three abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2022, which convenes in Paris, France from September 9-13, 2022. Tempus is presenting all three abstracts, including one oral presentation and two poster…
SAN FRANCISCO, Sept. 8, 2022 /PRNewswire/ — Verana Health®—a digital health company elevating quality in real-world data—today announced it will present two research posters at the American College of Epidemiology (ACE) 2022 Annual Meeting, which will be held Sept. 8-11 in Scottsdale, Arizona. Both research projects demonstrate the value of using quality, de-identified real-world data (RWD)…
Minneapolis, MN – WEBWIRE – Wednesday, September 7, 2022 “Partnering with ENT Partners contributes to our mission to deliver the largest secure, privacy-compliant, real-world ENT dataset for researchers around the world,” Omer Dror, CEO & co-founder, Lynx.MD Lynx.MD today announced that they have partnered with ENT Partners (ENT&C Management, LLC), a leading Physician…
Datavant launches international expansion and acquires Convenet, a health technology infrastructure company in the UK that has built the world’s first NHS approved API powering integration into the NHS Spine for patient-consented data exchange. Datavant will develop tokenization capabilities in the UK to enable clinical trial data to be linked…